February 28, 2022
A California federal judge has given final approval to a $3.65 million class action settlement against StemGenex Medical Group Inc., a stem cell therapy provider that filed for Chapter 7 in 2019, for misleadingly marketing and selling treatments to patients suffering from "incurable diseases and a dearth of hope."
September 10, 2019
A medical group facing a certified class action for its alleged fraudulent marketing of stem cell treatments has told a California federal court that it has filed for bankruptcy and will liquidate the business.
June 25, 2019
Stem cell therapy patients accusing a provider of wrongfully marketing and selling stem cell treatments nationwide have attained class certification by a whisker, as a California federal judge cautioned of "dangers down the road" in the "complex and troubling case."
January 17, 2017
A stem cell therapy provider accused of wrongfully marketing and selling stem cell treatments to patients nationwide told a California federal judge Monday to scrap the proposed fraud class action, calling it nothing more than a "fishing expedition."